Mario Losen

5.2k total citations · 1 hit paper
77 papers, 3.4k citations indexed

About

Mario Losen is a scholar working on Neurology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mario Losen has authored 77 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 19 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mario Losen's work include Myasthenia Gravis and Thymoma (30 papers), Peripheral Neuropathies and Disorders (25 papers) and Autoimmune Neurological Disorders and Treatments (14 papers). Mario Losen is often cited by papers focused on Myasthenia Gravis and Thymoma (30 papers), Peripheral Neuropathies and Disorders (25 papers) and Autoimmune Neurological Disorders and Treatments (14 papers). Mario Losen collaborates with scholars based in Netherlands, Belgium and United States. Mario Losen's co-authors include Pilar Martínez‐Martínez, Marc H. De Baets, Jochen Büchs, Peter Molenaar, Janine Schuurman, Paul W.H.I. Parren, Jan J.G.M. Verschuuren, Tom Vink, Wim K. Bleeker and Ellen Vermeulen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mario Losen

76 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

2007 707 citations Mario Losen, Pilar Martínez‐Martínez et al. profile →

Peers

Countries citing papers authored by Mario Losen

Since Specialization

Citations

This map shows the geographic impact of Mario Losen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Losen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Losen more than expected).

Fields of papers citing papers by Mario Losen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Losen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Losen. The network helps show where Mario Losen may publish in the future.

Co-authorship network of co-authors of Mario Losen

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Losen. A scholar is included among the top collaborators of Mario Losen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Losen. Mario Losen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations 2025 ·Neurobiology of Disease ·(unknown), Mario Losen, Jonas Dehairs, Johannes V. Swinnen, Etienne Waelkens, (unknown), Pilar Martínez‐Martínez	0
2	The effects of APOE4 and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age‐ and sex‐dependent 2024 ·Journal of Neurochemistry ·Sandra den Hoedt, Simone M. Crivelli, (unknown), Frank Leijten, Mario Losen, Helga E. de Vries, Eric J.G. Sijbrands, Adrie J.M. Verhoeven, Pilar Martínez‐Martínez, Monique Mulder	1
3	Sphingolipids in Alzheimer's disease, how can we target them? 2020 ·Advanced Drug Delivery Reviews ·Simone M. Crivelli, (unknown), (unknown), (unknown), Nienke M. de Wit, Sandra den Hoedt, Mario Losen, Monique Mulder, Jochen Walter, Helga E. de Vries, Erhard Bieberich, Pilar Martínez‐Martínez	60
4	Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient 2017 ·Scientific Reports ·Abhishek Saxena, Jo Stevens, Hakan Çetin, Inga Koneczny, Richard Webster, Konstantinos Lazaridis, Socrates J. Tzartos, Kathleen Vrolix, Gisela Nogales‐Gadea, Barbie M. Machiels, Peter Molenaar, Jan Damoiseaux, Marc H. De Baets, Katja Simon‐Keller, Alexander Marx, Angela Vincent, Mario Losen, Pilar Martínez‐Martínez	15
5	Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression? 2017 ·Frontiers in Immunology ·(unknown), (unknown), Marina Mané-Damas, Peter Molenaar, Mario Losen, Pilar Martínez‐Martínez	14
6	TrkB in the hippocampus and nucleus accumbens differentially modulates depression-like behavior in mice 2015 ·Behavioural Brain Research ·Jochen De Vry, Tim Vanmierlo, Pilar Martínez‐Martínez, Mario Losen, Yasin Temel, Janneke Boere, Günter Kenis, Thomas Steckler, Harry W.M. Steinbusch, Marc De Baets, Jos Prickaerts	27
7	MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4 2013 ·Proceedings of the National Academy of Sciences ·Maartje G. Huijbers, Wei Zhang, Rinse Klooster, E. Niks, Matthew B. Friese, Kirsten R. Straasheijm, Peter Thijssen, Hans Vrolijk, Jaap J. Plomp, (unknown), Mario Losen, Silvère M. van der Maarel, Steven J. Burden, Jan J.G.M. Verschuuren	210
8	Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4 2013 ·Autoimmunity Reviews ·Jan J.G.M. Verschuuren, Maartje G. Huijbers, Jaap J. Plomp, E. Niks, Peter Molenaar, Pilar Martínez‐Martínez, Alejandro M. Gomez, Marc H. De Baets, Mario Losen	128
9	Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders 2013 ·Frontiers in Genetics ·Pilar Martínez‐Martínez, Peter Molenaar, Mario Losen, Jo Stevens, Marc H. De Baets, Andreı̈ Szöke, Jérôme Honnorat, Ryad Tamouza, Marion Leboyer, Jim van Os, Bart P. F. Rutten	11
10	Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis? 2012 ·Annals of the New York Academy of Sciences ·Alejandro M. Gomez, Nick Willcox, Peter Molenaar, Wim A. Buurman, Pilar Martínez‐Martínez, Marc H. De Baets, Mario Losen	34
11	Goodpasture Antigen-binding Protein/Ceramide Transporter Binds to Human Serum Amyloid P-Component and Is Present in Brain Amyloid Plaques 2012 ·Journal of Biological Chemistry ·Chiara Mencarelli, (unknown), Mario Losen, (unknown), Peter Molenaar, Robert Veerhuis, Harry W.M. Steinbusch, Marc H. De Baets, Gerry A. F. Nicolaes, Pilar Martínez‐Martínez	29
12	Neuropathy-Induced Spinal GAP-43 Expression Is Not a Main Player in the Onset of Mechanical Pain Hypersensitivity 2011 ·Journal of Neurotrauma ·(unknown), Sebastiaan van Gorp, Elbert A.J. Joosten, Mario Losen, Pilar Martínez‐Martínez, Marc De Baets, Marco A. E. Marcus, Ronald Deumens	13
13	Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis 2010 ·Journal of Neuroimmunology ·Kathleen Vrolix, E. Niks, Rozen Le Panse, (unknown), Anne‐Hilde Muris, (unknown), Maarten J. D. van Tol, Mario Losen, Peter Molenaar, E.J.J. van Zoelen, Sonia Berrih‐Aknin, (unknown), Jan J.G.M. Verschuuren, Pilar Martínez‐Martínez	8
14	Low Current-driven Micro-electroporation Allows Efficient In Vivo Delivery of Nonviral DNA into the Adult Mouse Brain 2010 ·Molecular Therapy ·Jochen De Vry, Pilar Martínez‐Martínez, Mario Losen, (unknown), Yasin Temel, Thomas Steckler, Harry W.M. Steinbusch, Marc De Baets, Jos Prickaerts	28
15	The Effect of Plasma From Muscle-Specific Tyrosine Kinase Myasthenia Patients on Regenerating Endplates 2009 ·American Journal Of Pathology ·(unknown), Pilar Martínez‐Martínez, Mario Losen, Marc H. De Baets, Axel R. Wintzen, Jan J.G.M. Verschuuren, E. Niks, Sjoerd G. van Duinen, Angela Vincent, Peter Molenaar	32
16	Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis 2005 ·Brain ·Mario Losen, (unknown), Pilar Martínez‐Martínez, Barbie M. Machiels, Hans Duimel, Peter M. Frederik, Henk Veldman, John H. J. Wokke, Frank Spaans, Angela Vincent, Marc H. De Baets	56
17	DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content 2004 ·Journal of Lipid Research ·(unknown), Matthijs K. C. Hesselink, Gert Schaart, Esther Moonen‐Kornips, Pilar Martínez‐Martínez, Mario Losen, Marc H. De Baets, Ronald P. Mensink, Patrick Schrauwen	40
18	2004 ·Biotechnology Progress ·Mario Losen, (unknown), Martina Pohl, Jochen Büchs	152
19	Effect of oxygen supply on passaging, stabilising and screening of recombinant production strains in test tube cultures 2003 ·FEMS Yeast Research ·(unknown), Mario Losen, Ulrike Dahlems, (unknown), Gerd Gellissen, Jochen Büchs	40
20	Immunoregulation in Experimental Autoimmune Myasthenia Gravis—about T Cells, Antibodies, and Endplates 2003 ·Annals of the New York Academy of Sciences ·Marc De Baets, (unknown), Mario Losen, (unknown), Barbie M. Machiels	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact